JTK-853 is a bioactive compound. JTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection. References: Gentile I, Buonomo AR, Zappulo E, Borgia G. Discontinued drugs in 2012 - 2013: hepatitis C virus infection. Expert Opin Investig Drugs. 2015 Feb;24(2):239-51. doi: 10.1517/13543784.2015.982274. Epub 2014 Nov 11. PubMed PMID: 25384989.

纯度：≥98%

CAS：954389-09-4